Genetic basis of nicotine withdrawal in a reduced complexity cross
降低复杂性杂交中尼古丁戒断的遗传基础
基本信息
- 批准号:10401810
- 负责人:
- 金额:$ 55.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectiveAftercareAllelesAmygdaloid structureAnimal ModelBehaviorBehavioralBiologicalBrain regionCRISPR/Cas technologyCandidate Disease GeneCell NucleusCessation of lifeChronicComplexDataDevelopmentEtiologyFemaleFutureGene TargetingGenesGeneticGenetic VariationGenetic studyGenomeGenomic SegmentGenomicsHealthHumanHuman GenomeIndividualLeadMapsMeasuresMediatingModelingMolecularMusNeurobiologyNeuronal PlasticityNeuronsNicotineNicotine DependenceNicotine WithdrawalNucleus AccumbensPathway AnalysisPathway interactionsPhenotypePredispositionPublishingQuantitative Trait LociRelapseSalineSmokingSystemTimeTissue-Specific Gene ExpressionTissuesTobaccoTobacco smoking behaviorVariantWithdrawalbasebehavior changecandidate validationdifferential expressionepidemiologic datagene functiongene networkgenetic architecturegenetic variantgenome editinginsightmRNA sequencingmalemouse genomemouse modelnicotine abusenicotine cessationnicotine exposurenicotine usenovelnovel therapeuticsnull mutationresilienceresponsesmoking addictionsmoking cessationtherapy developmenttooltraittranscriptometranscriptome sequencingtranslational genetics
项目摘要
Project Summary
Despite evidence of strong genetic contributions to the etiology of nicotine dependence
(ND), we are far from identifying the specific genetic bases of individual susceptibility to
ND. The primary objective of this proposal is to identify novel genetic factors that
contribute to nicotine withdrawal, an important aspect of ND that contribute relapse, in
mice. We observed pronounced nicotine withdrawal traits differences in C57BL/6NJ
strain but not in the closely related C57BL/6J substrain. Because the parental substrains
are nearly genetically identical, quantitative trait locus (QTL) mapping in an experimental
F2 cross (Reduced Complexity Cross; RCC) will greatly facilitate the identification of
novel genetic factors that underlie differences in withdrawal behaviors. In Aim 1, we will
use the RCC to map genomic regions, or QTLs, that are causally associated with
susceptibility versus resilience to multiple measures of nicotine withdrawal. In Aim 2, we
will conduct transcriptome analysis via mRNA sequencing (RNA-seq) of four brain
regions regions in control mice and chronic nicotine-treated mice from the parental male
and female C57BL/6J and C57BL/6NJ substrains. The transcriptome in control mice will
serve as a useful tool both in identifying candidate genes for future genome editing that
are differentially expressed and underlie the behavioral QTLs as well as providing
genomic insight into the neuronal context that influences susceptibility versus resilience
to nicotine withdrawal. Genes that are differentially expressed as a consequence of
nicotine will reveal changes in the transcriptome relevant to central neuronal plasticity
and the behaviors/changes that support ND. In Aim 3, we will validate candidate
quantitative trait genes and functional variants identified and ranked by Aims 1-2.
项目概要
尽管有证据表明遗传因素对尼古丁依赖的病因有很大影响
(ND),我们还远远没有确定个体易感性的具体遗传基础
ND。该提案的主要目标是确定新的遗传因素
导致尼古丁戒断,这是 ND 导致复发的一个重要方面,
老鼠。我们观察到 C57BL/6NJ 中明显的尼古丁戒断特征差异
菌株,但不在密切相关的 C57BL/6J 亚菌株中。因为父母的基因
基因几乎相同,在实验中进行数量性状位点(QTL)定位
F2杂交(Reduced Complexity Cross;RCC)将大大方便鉴定
造成戒断行为差异的新遗传因素。在目标 1 中,我们将
使用 RCC 来绘制基因组区域或 QTL,这些区域与
对多种尼古丁戒断措施的敏感性与抵抗力。在目标 2 中,我们
将通过 mRNA 测序 (RNA-seq) 对四个大脑进行转录组分析
对照小鼠和来自亲本雄性的慢性尼古丁治疗小鼠的区域
以及雌性 C57BL/6J 和 C57BL/6NJ 亚系。对照小鼠的转录组将
作为一个有用的工具,可以识别未来基因组编辑的候选基因
差异表达,是行为 QTL 的基础,并提供
对影响易感性与弹性的神经元环境的基因组洞察
尼古丁戒断。差异表达的基因
尼古丁将揭示与中枢神经元可塑性相关的转录组的变化
以及支持 ND 的行为/变化。在目标 3 中,我们将验证候选人
按目标 1-2 鉴定和排序数量性状基因和功能变异。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Investigating the role of nicotinic acetylcholine receptors in menthol's effects in mice.
研究烟碱乙酰胆碱受体在薄荷醇对小鼠的作用中的作用。
- DOI:
- 发表时间:2024-04-01
- 期刊:
- 影响因子:4.2
- 作者:Akinola, Lois S;Gonzales, Jada;Buzzi, Belle;Mathews, Hunter L;Papke, Roger L;Stitzel, Jerry A;Damaj, M Imad
- 通讯作者:Damaj, M Imad
Characterization of single nucleotide polymorphisms for a forward genetics approach using genetic crosses in C57BL/6 and BALB/c substrains of mice.
使用 C57BL/6 和 BALB/c 小鼠亚系的遗传杂交来表征正向遗传学方法的单核苷酸多态性。
- DOI:
- 发表时间:2022-05-20
- 期刊:
- 影响因子:2.4
- 作者:Miura, Ikuo;Kikkawa, Yoshiaki;Yasuda, Shumpei P;Shinogi, Akiko;Usuda, Daiki;Kumar, Vivek;Takahashi, Joseph S;Tamura, Masaru;Masuya, Hiroshi;Wakana, Shigeharu
- 通讯作者:Wakana, Shigeharu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Imad Damaj其他文献
M. Imad Damaj的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Imad Damaj', 18)}}的其他基金
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
靶向 1-磷酸鞘氨醇 (S1P1) 受体治疗芳香酶抑制剂引起的肌肉骨骼症状
- 批准号:
10668781 - 财政年份:2023
- 资助金额:
$ 55.42万 - 项目类别:
Initial Development of AEG-1 inactivation as a possible strategy for pain treatment
初步开发 AEG-1 失活作为疼痛治疗的可能策略
- 批准号:
10454012 - 财政年份:2022
- 资助金额:
$ 55.42万 - 项目类别:
VCU Health Education Opportunities for Teachers (HERO-T)
VCU 教师健康教育机会 (HERO-T)
- 批准号:
10399423 - 财政年份:2021
- 资助金额:
$ 55.42万 - 项目类别:
VCU Health Education Opportunities for Teachers (HERO-T)
VCU 教师健康教育机会 (HERO-T)
- 批准号:
10596118 - 财政年份:2021
- 资助金额:
$ 55.42万 - 项目类别:
Identification of gene variants for alcohol analgesia
酒精镇痛基因变异的鉴定
- 批准号:
9758078 - 财政年份:2019
- 资助金额:
$ 55.42万 - 项目类别:
Identification of gene variants for alcohol analgesia
酒精镇痛基因变异的鉴定
- 批准号:
10598056 - 财政年份:2019
- 资助金额:
$ 55.42万 - 项目类别:
Identification of gene variants for alcohol analgesia
酒精镇痛基因变异的鉴定
- 批准号:
10380160 - 财政年份:2019
- 资助金额:
$ 55.42万 - 项目类别:
Genetic basis of nicotine withdrawal in a reduced complexity cross
降低复杂性杂交中尼古丁戒断的遗传基础
- 批准号:
9920699 - 财政年份:2018
- 资助金额:
$ 55.42万 - 项目类别:
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
(PQ12) 过氧化物酶体增殖物激活受体α激动剂作为化疗引起的周围神经病变的潜在治疗方法
- 批准号:
10198858 - 财政年份:2018
- 资助金额:
$ 55.42万 - 项目类别:
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
(PQ12) 过氧化物酶体增殖物激活受体α激动剂作为化疗引起的周围神经病变的潜在治疗方法
- 批准号:
9750651 - 财政年份:2018
- 资助金额:
$ 55.42万 - 项目类别:
相似海外基金
Intravitreal gene therapy for inherited retinal disease
遗传性视网膜疾病的玻璃体内基因治疗
- 批准号:
10660784 - 财政年份:2023
- 资助金额:
$ 55.42万 - 项目类别:
Metabolic and neural activity normalization by cerebral blood flow increase in AD/ADRD models
AD/ADRD 模型中脑血流量增加使代谢和神经活动正常化
- 批准号:
10657935 - 财政年份:2023
- 资助金额:
$ 55.42万 - 项目类别:
Next generation T cell therapies for mutant KRAS solid tumors
针对突变 KRAS 实体瘤的下一代 T 细胞疗法
- 批准号:
10731929 - 财政年份:2023
- 资助金额:
$ 55.42万 - 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 55.42万 - 项目类别:
Characterizing Entorhinal Cortex Circuit Dysfunction in an APOE Mouse Model of Chemotherapy-Induced Cognitive Impairment
化疗引起认知障碍的 APOE 小鼠模型中内嗅皮层回路功能障碍的特征
- 批准号:
10677984 - 财政年份:2023
- 资助金额:
$ 55.42万 - 项目类别: